Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Collier

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2002
Central venous catheter-related bacteremia due to Tsukamurella species in the immunocompromised host: a case series and review of the literatureM A Schwartz, S R Tabet, A C Collier, et al.
The International Journal of Neuroscience|May 1, 1993
Cognitive risk factors and neuropsychological performance in HIV infectionK H Claypoole, B D Townes, A C Collier, et al.
Lancet (London, England)|March 9, 1991
Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoproteinE L Cooney, A C Collier, P D Greenberg, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|October 1, 1995
Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complexA C Collier, R W Coombs, D Katzenstein, et al.
The New England Journal of Medicine|October 11, 1990
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials GroupM A Fischl, C B Parker, C Pettinelli, et al.
JAMA|January 14, 2000
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimensD V Havlir, N S Hellmann, C J Petropoulos, et al.
Journal of Acquired Immune Deficiency Syndromes|January 11, 1992
Central nervous system manifestations in human immunodeficiency virus infection without AIDSA C Collier, C Marra, R W Coombs, et al.
Annals of Internal Medicine|January 1, 1995
Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials GroupM A Fischl, K Stanley, A C Collier, et al.
AJNR. American Journal of Neuroradiology|July 11, 1992
Prospective cerebral MR study of HIV seropositive and seronegative men: correlation of MR findings with neurologic, neuropsychologic, and cerebrospinal fluid analysisW A Cohen, K R Maravilla, R Gerlach, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1993
Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 proteinE L Cooney, M J McElrath, L Corey, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2002
Central venous catheter-related bacteremia due to Tsukamurella species in the immunocompromised host: a case series and review of the literatureM A Schwartz, S R Tabet, A C Collier, et al.
The International Journal of Neuroscience|May 1, 1993
Cognitive risk factors and neuropsychological performance in HIV infectionK H Claypoole, B D Townes, A C Collier, et al.
Lancet (London, England)|March 9, 1991
Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoproteinE L Cooney, A C Collier, P D Greenberg, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|October 1, 1995
Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complexA C Collier, R W Coombs, D Katzenstein, et al.
The New England Journal of Medicine|October 11, 1990
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials GroupM A Fischl, C B Parker, C Pettinelli, et al.
JAMA|January 14, 2000
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimensD V Havlir, N S Hellmann, C J Petropoulos, et al.
Journal of Acquired Immune Deficiency Syndromes|January 11, 1992
Central nervous system manifestations in human immunodeficiency virus infection without AIDSA C Collier, C Marra, R W Coombs, et al.
Annals of Internal Medicine|January 1, 1995
Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials GroupM A Fischl, K Stanley, A C Collier, et al.
AJNR. American Journal of Neuroradiology|July 11, 1992
Prospective cerebral MR study of HIV seropositive and seronegative men: correlation of MR findings with neurologic, neuropsychologic, and cerebrospinal fluid analysisW A Cohen, K R Maravilla, R Gerlach, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1993
Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 proteinE L Cooney, M J McElrath, L Corey, et al.
Pageof 14